Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies (Q34459963)

2 August 2017

4 references

2 October 2019

24 November 2020

4 December 2020

4 February 2021

1 reference

title

Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies (English)

1 reference

randomized controlled trial

2 August 2017

main subject

arterial hypertension

1 reference

2 October 2019

2 references

2 October 2019

4 February 2021

1 reference

angiotensin II receptor antagonist

19 September 2019

1 reference

2 October 2019

1 reference

antihypertensive drug

2 references

4 December 2020

2 references

24 November 2020

1 reference

Guang Hao

1 reference

2 August 2017

Zengwu Wang

1 reference

2 August 2017

Rui Guo

1 reference

2 August 2017

Zuo Chen

1 reference

2 August 2017

Xin Wang

1 reference

2 August 2017

Linfeng Zhang

1 reference

2 August 2017

Wei Li

1 reference

2 August 2017

language of work or name

1 reference

25 October 2014

10 references

BMC Cardiovascular Disorders

2 August 2017

13 March 2019

14 March 2019

24 March 2019

17 June 2019

19 September 2019

2 October 2019

24 November 2020

4 December 2020

4 February 2021

10 references

2 August 2017

13 March 2019

14 March 2019

24 March 2019

17 June 2019

19 September 2019

2 October 2019

24 November 2020

4 December 2020

4 February 2021

1 reference

2 August 2017

page(s)

148

1 reference

Creative Commons Attribution

2 August 2017

9 references

13 March 2019

14 March 2019

24 March 2019

17 June 2019

19 September 2019

2 October 2019

24 November 2020

4 December 2020

4 February 2021

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Cardiovascular disease in recent onset diabetes mellitus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Effect of valsartan on the incidence of diabetes and cardiovascular events

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Diabetes, hypertension, and cardiovascular disease: an update

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

6 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

6 July 2018

https://api.crossref.org/works/10.1186%2F1471-2261-14-148

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-14-148

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-14-148

Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-14-148

Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-14-148

Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia-Pacific region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-14-148

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-14-148

2013 ESH/ESC guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4221690

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

27 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-14-148

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-14-148

Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-14-148

Increases in Antihypertensive Prescriptions and Reductions in Cardiovascular Events in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-14-148

Diabetes mellitus and hypertension in the elderly: concomitant hyperlipidemia and coronary heart disease risk

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/25344747

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/25344747

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/25344747

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2261-14-148

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference